142 related articles for article (PubMed ID: 4049843)
1. [Specific safety and immunogenicity of a subunit vaccine against hepatitis B].
Viazov SO; Vlasikhina EM; Margolina AN; Favorov MO; Poverennyĭ AM
Vopr Virusol; 1985; 30(3):324-7. PubMed ID: 4049843
[TBL] [Abstract][Full Text] [Related]
2. The safety and immunogenicity of a recombinant hepatitis B vaccine in neonates.
Gunn TR; Bosley A; Woodfield DG
N Z Med J; 1989 Jan; 102(860):1-3. PubMed ID: 2521527
[TBL] [Abstract][Full Text] [Related]
3. [Clinical and immunological studies of an experimental series of vaccines against hepatitis B].
Teokharova MP; Andonov AP; Mineva EG; Draganov PI
Vopr Virusol; 1984; 29(4):483-7. PubMed ID: 6495708
[TBL] [Abstract][Full Text] [Related]
4. [Verification of the safety, inoculability, reactogenicity and antigenic properties of a live recombinant smallpox-hepatitis B vaccine in an experiment in volunteers].
Chernos VI; Cheliapov NV; Antonova TP; Rakhilina LE; Unanov SS; Al'tshteĭn AD; Zakharova LG; Fodor II; Bendukidze KA; Komarov FI
Vopr Virusol; 1990; 35(2):132-5. PubMed ID: 2167564
[TBL] [Abstract][Full Text] [Related]
5. Immunogenicity of hepatitis B vaccine in Chinese school children: a comparison of two plasma-derived vaccines.
Lee SD; Lo KJ; Tsai YT; Chan CY; Wu TC; Hwang SJ; Chang CP; Huang YS
Zhonghua Yi Xue Za Zhi (Taipei); 1988 Aug; 42(2):87-92. PubMed ID: 3066454
[No Abstract] [Full Text] [Related]
6. Immunogenicity and side effects of low dose intradermally administered hepatitis B vaccine.
Pathak UN; Dilawari JB; Chawla Y; Sokhey CS; Sharma BK; Ganguly NK
Indian J Gastroenterol; 1988 Apr; 7(2):113-4. PubMed ID: 2966113
[No Abstract] [Full Text] [Related]
7. [A plasma subunit vaccine against hepatitis B studied in field trials].
Ikoev VN; Gorbunov MA; Anan'ev VA; Sumarokov AA; Shavakhabov ShSh; Khalitova KA
Zh Mikrobiol Epidemiol Immunobiol; 1990 Jun; (6):53-8. PubMed ID: 2145718
[TBL] [Abstract][Full Text] [Related]
8. [Immunological and epidemiological effectiveness of the HEVAC B vaccine against hepatitis B in a group at enhanced risk of infection].
Khukhlovich PA; Viazov SO; Shakhgil'dian IV; Anan'ev VA; Braginskiĭ DM
Vopr Virusol; 1985; 30(3):330-3. PubMed ID: 4049844
[TBL] [Abstract][Full Text] [Related]
9. Intramuscular versus low-dose intradermal hepatitis B vaccine. Assessment by humoral and cellular immune response to hepatitis B surface antigen.
Frazer IH; Jones B; Dimitrakakis M; Mackay IR
Med J Aust; 1987 Mar; 146(5):242-5. PubMed ID: 2950303
[TBL] [Abstract][Full Text] [Related]
10. Clinical evaluation of low-dose intradermally administered hepatitis B virus vaccine. A cost reduction strategy.
Redfield RR; Innis BL; Scott RM; Cannon HG; Bancroft WH
JAMA; 1985 Dec; 254(22):3203-6. PubMed ID: 2933535
[TBL] [Abstract][Full Text] [Related]
11. The evaluation of Engerix-B in healthy Malaysian medical students.
Isahak I; Abdul Malik Y; Hakim AS; Baharin R
Singapore Med J; 1990 Aug; 31(4):314-6. PubMed ID: 2147781
[TBL] [Abstract][Full Text] [Related]
12. Protective efficacy of a recombinant DNA hepatitis B vaccine in neonates of HBe antigen-positive mothers.
Poovorawan Y; Sanpavat S; Pongpunlert W; Chumdermpadetsuk S; Sentrakul P; Safary A
JAMA; 1989 Jun; 261(22):3278-81. PubMed ID: 2523981
[TBL] [Abstract][Full Text] [Related]
13. [Effectiveness and tolerance of genetically engineered vaccines for hepatitis B--a comparative study].
Schmid K; Strebl H; Heck KJ; Weltle D; Raithel HJ
Gesundheitswesen; 1992 May; 54(5):219-22. PubMed ID: 1535816
[TBL] [Abstract][Full Text] [Related]
14. Reversal by intradermal hepatitis B vaccination of unresponsiveness to HBsAg.
Nagafuchi S; Kashiwagi S
Lancet; 1987 Dec; 2(8574):1522-3. PubMed ID: 2892077
[No Abstract] [Full Text] [Related]
15. [Active hepatitis B immunization--current status of development and effectiveness].
Baumgarten R; Fengler JD
Z Arztl Fortbild (Jena); 1986; 80(10):393-4. PubMed ID: 2944291
[No Abstract] [Full Text] [Related]
16. Dose range study in healthy volunteers of a hepatitis B vaccine produced in yeast.
Kuwert E; Scheiermann N; Gesemann M; Paar D; Safary A; Simoen E; Hauser P; Andre F
Antiviral Res; 1985; Suppl 1():281-8. PubMed ID: 2935080
[No Abstract] [Full Text] [Related]
17. Mass vaccination against hepatitis B in preschool children: immunogenicity after three reduced doses.
Milne A; Moyes CD; Waldon J; Pearce NE; Krugman S
N Z Med J; 1989 Aug; 102(874):429-30. PubMed ID: 2527346
[TBL] [Abstract][Full Text] [Related]
18. Low dose hepatitis B vaccination in children: benefit of low dose boosters.
Milne A; Moyes CD; Dimitrakakis M
N Z Med J; 1988 Jun; 101(847 Pt 1):370-1. PubMed ID: 2970604
[TBL] [Abstract][Full Text] [Related]
19. Persistence of vaccine-induced antibodies to hepatitis B surface antigen and the need for booster vaccination in adult subjects.
Ambrosch F; Frisch-Niggemeyer W; Kremsner P; Kunz C; André F; Safary A; Wiedermann G
Postgrad Med J; 1987; 63 Suppl 2():129-35. PubMed ID: 3317348
[TBL] [Abstract][Full Text] [Related]
20. [Response of healthy subjects to plasma-derived anti-hepatitis B vaccine].
Curciarello JO; Echeverría RF; Jmelnitzky A; Chiera A; Bolzan H; Pérez C; Corallini O
Acta Gastroenterol Latinoam; 1991; 21(4):237-40. PubMed ID: 1824180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
